Tamoxifen

• The National Cancer Institute concluded in 2001:

  • Tamoxifen DID NOT effect the rate of CV events in women with or without coronary disease.
  • We can say that Tamoxifen IS NOT associated with an increased CV event rate.

Previous slide

Back to first slide

View graphic version